These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 29860768)

  • 1. The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.
    Ying ZT; Zheng W; Wang XP; Xie Y; Tu MF; Lin NJ; Ping LY; Liu WP; Deng LJ; Zhang C; Zhu J; Song YQ
    Chin J Cancer; 2012 Jul; 31(7):348-53. PubMed ID: 22704490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study.
    Li W; Chang Y; Liu X; Chen Z; Sun J; Geng Z; Zhang M; Zhang L
    Ann Hematol; 2024 Jun; 103(6):2003-2012. PubMed ID: 38308020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.
    Griffiths R; Mikhael J; Gleeson M; Danese M; Dreyling M
    Blood; 2011 Nov; 118(18):4808-16. PubMed ID: 21873544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
    Ruan J; Martin P; Coleman M; Furman RR; Cheung K; Faye A; Elstrom R; Lachs M; Hajjar KA; Leonard JP
    Cancer; 2010 Jun; 116(11):2655-64. PubMed ID: 20235190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma.
    Sarkozy C; Callanan M; Thieblemont C; Obéric L; Burroni B; Bouabdallah K; Damaj G; Tessoulin B; Ribrag V; Houot R; Morschhauser F; Griolet S; Joubert C; Cacheux V; Delwail V; Safar V; Gressin R; Cheminant M; Delfau-Larue MH; Hermine O; Macintyre E; Le Gouill S
    Blood; 2024 Jul; 144(3):262-271. PubMed ID: 38669626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of
    Carras S; Torroja A; Emadali A; Montaut E; Daguindau N; Tempescul A; Moreau A; Tchernonog E; Schmitt A; Houot R; Dartigeas C; Barbieux S; Corm S; Banos A; Fouillet L; Dupuis J; Macro M; Fleury J; Jardin F; Sarkozy C; Damaj G; Feugier P; Fornecker LM; Chabrot C; Dorvaux V; Bouabdallah K; Amorim S; Garidi R; Voillat L; Joly B; Morineau N; Moles MP; Zerazhi H; Fontan J; Arkam Y; Alexis M; Delwail V; Vilque JP; Ysebaert L; Burroni B; Callanan M; Le Gouill S; Gressin R
    Haematologica; 2024 Jun; 109(6):1857-1865. PubMed ID: 38031755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, clinical and therapeutic profiles of mantle cell lymphoma cared for in a Moroccan center: a review of 14 cases.
    Abakarim O; Mansouri A; Hebbezni A; Boujguenna I; Lahlimi FE; Tazi I
    Pan Afr Med J; 2024; 47():111. PubMed ID: 38828423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
    Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
    [No Abstract]   [Full Text] [Related]  

  • 10. Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
    Hsi ED; Jung SH; Lai R; Johnson JL; Cook JR; Jones D; Devos S; Cheson BD; Damon LE; Said J
    Leuk Lymphoma; 2008 Nov; 49(11):2081-90. PubMed ID: 19021050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
    Holte H; Beiske K; Boyle M; Trøen G; Blaker YN; Myklebust J; Kvaløy S; Rosenwald A; Lingjaerde OC; Rimsza LM; Smeland EB; Scott DW; Kolstad A
    Br J Haematol; 2018 Oct; 183(2):225-234. PubMed ID: 30080252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features and prognosis analysis of bone marrow biopsy involvement in 95 cases with mantle cell lymphoma].
    Wang Y; Wang H; Zhang JF; Zhang NH; Ding XY; Shi XJ; Wang R
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):616-618. PubMed ID: 38825910
    [No Abstract]   [Full Text] [Related]  

  • 13. Is rituximab retro in mantle cell lymphoma?
    Ryan CE; Cohen JB
    Blood; 2024 Jul; 144(3):241-243. PubMed ID: 39023870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic Significance of Progression of Disease within 24 Months in Mantle Cell Lymphoma].
    Ma RX; Zhang QQ; Chen HM; Hu J; Lu FY; Han QN; Li ZY; Xu KL; Chen W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):702-707. PubMed ID: 38926956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma characterized by numerous diffuse polypoid lesions along the entire digestive tract: A case report.
    Cheng S; Yang L; Wang X
    Oncol Lett; 2024 Aug; 28(2):363. PubMed ID: 38903699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive necrotizing xanthogranuloma in both eyes: a case report].
    Yang WY; Chen H; Ren RX; Xie Y; Wang JH; Wu S; Ji M
    Zhonghua Yan Ke Za Zhi; 2024 May; 60(5):447-450. PubMed ID: 38706083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.
    Duminuco A; Romano A; Ferrarini I; Santuccio G; Chiarenza A; Figuera A; Caruso LA; Motta G; Palumbo GA; Mogno C; Moioli A; Di Raimondo F; Visco C
    Ann Hematol; 2024 Apr; ():. PubMed ID: 38630129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 140 cases of mantle cell lymphoma].
    Hu MW; Lou YJ; Yang M; Wang HF; Wang L; Jin J
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):390-395. PubMed ID: 29860768
    [No Abstract]   [Full Text] [Related]  

  • 19. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
    Robak T; Jin J; Pylypenko H; Verhoef G; Siritanaratkul N; Drach J; Raderer M; Mayer J; Pereira J; Tumyan G; Okamoto R; Nakahara S; Hu P; Appiani C; Nemat S; Cavalli F;
    Lancet Oncol; 2018 Nov; 19(11):1449-1458. PubMed ID: 30348538
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.